As he prepares to lead, Burnham faces pressure over controversial tech contracts tied to military and immigration enforcement
Category: Health
As Andy Burnham gears up to potentially become the next Prime Minister of the United Kingdom on July 20, 2026, he is reportedly considering distancing the National Health Service (NHS) from the controversial US technology firm Palantir. This move could end Palantir's £330 million contract with the NHS, a decision driven by growing concerns about the company's role in government technology and artificial intelligence strategy. The situation has sparked intense debate, especially among Labour MPs and advocacy groups who question the ethical implications of continuing this partnership.
Currently, Palantir operates the NHS Federated Data Platform under a seven-year contract signed in 2024, which is utilized by over half of NHS trusts in England. The platform has been credited with facilitating more than 110,000 additional operations and improving operational efficiency, with reports indicating that hospitals piloting the platform have increased operating theatre utilization by approximately 12%. Supporters argue that abandoning the platform could disrupt these improvements, leading to concerns about patient care.
Burnham's consideration to terminate the NHS contract with Palantir is not yet finalized. Should he choose to end the agreement, he would need to notify the company by December 2026, ahead of the contract's automatic renewal in March 2027. The urgency of this decision is compounded by the political pressure surrounding Palantir's past associations, particularly its ties to the Israeli military and the U.S. Immigration and Customs Enforcement (ICE).
Palantir has faced scrutiny for its commercial relationships with the Israeli Defense Forces (IDF) and ICE. Critics, including left-wing Labour MPs and trade unions, have long called for the NHS to sever ties with the company due to these connections. In January 2024, Palantir announced a partnership with the Israeli Ministry of Defence to deploy technology for military operations, raising alarms about the ethical implications of such collaborations. Amnesty International has stated that Palantir's software supports Israel's actions in Gaza, calling for an end to its contracts in the NHS.
Supporters of the NHS's partnership with Palantir highlight the tangible benefits the platform has provided, including faster cancer diagnoses and reduced patient discharge delays. Shadow Health Secretary Stuart Andrew emphasized that if Burnham were to terminate a program that is improving patient care, he would need to justify prioritizing political concerns over patient outcomes. "If Andy Burnham tears up a programme that is improving patient care, he will have to explain why he chose politics over patients," Andrew said.
Conversely, critics argue that the ethical concerns surrounding Palantir's affiliations cannot be overlooked. The firm has been linked to controversial practices in the U.S., including its role in ICE's immigration enforcement operations, which have reportedly led to the identification and deportation of individuals. The ethical dilemmas posed by these associations have led to calls for a re-evaluation of the NHS's reliance on Palantir's technology, regardless of its operational benefits.
The political pressure surrounding Palantir's contract has been mounting, particularly in light of Sir Keir Starmer's resignation, which has paved the way for Burnham to potentially assume leadership of the Labour Party. During his tenure as the Mayor of Greater Manchester, Burnham refrained from awarding any contracts to Palantir, a stance that continues to influence his current deliberations. Allies of Burnham have indicated that his review of the UK's AI strategy reflects a growing concern about what one aide described as "unfettered tech boosterism," which risks alienating voters.
In recent months, 21 Labour MPs have criticized a separate £240 million Ministry of Defence contract awarded to Palantir without a competitive tender process. This scrutiny highlights the increasing focus on the ethical implications of public contracts with tech firms that have controversial backgrounds. Technology Secretary Liz Kendall has faced repeated questions about Palantir's role in the health service but has not explicitly called for its removal.
If Burnham follows through with terminating the contract, it would mark a historic precedent as the first time a large-scale NHS AI and data-analytics platform has been unwound for political rather than technical reasons. This decision could set a benchmark for how other public-sector contracts involving Palantir are examined, particularly in areas such as policing and defense, where similar ethical concerns are present.
As the debate continues, health officials and political leaders are grappling with the dual pressures of ensuring patient care and addressing ethical concerns surrounding technology partnerships. The upcoming months will be a practical decision window for Burnham's administration, as the NHS's reliance on Palantir's technology becomes a focal point of public discourse.
As the deadline for notifying Palantir approaches in December, the implications of Burnham's decision will echo beyond the NHS, potentially influencing public-sector procurement practices across the UK. The scrutiny of Palantir's contracts has already prompted discussions about the ethical responsibilities of government partnerships with technology firms. With the political climate rapidly changing, the decisions made in the coming months could redefine the relationship between public health services and technology companies in the UK.
As this situation develops, the public and political stakeholders will follow closely closely to see how Burnham navigates these complex issues, balancing the need for technological advancement with the ethical ramifications of partnering with companies like Palantir.